Embla Medical hf (Embla Medical hf) FCF Margin % : -3.73% (As of Mar. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Embla Medical hf FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Embla Medical hf's Free Cash Flow for the three months ended in Mar. 2024 was $-7.4 Mil. Embla Medical hf's Revenue for the three months ended in Mar. 2024 was $199.9 Mil. Therefore, Embla Medical hf's FCF Margin % for the quarter that ended in Mar. 2024 was -3.73%.

As of today, Embla Medical hf's current FCF Yield % is 2.59%.

The historical rank and industry rank for Embla Medical hf's FCF Margin % or its related term are showing as below:

OSSUY' s FCF Margin % Range Over the Past 10 Years
Min: 4.85 Med: 8.93 Max: 13.42
Current: 5.82

During the past 13 years, the highest FCF Margin % of Embla Medical hf was 13.42%. The lowest was 4.85%. And the median was 8.93%.

OSSUY's FCF Margin % is ranked better than
71.39% of 825 companies
in the Medical Devices & Instruments industry
Industry Median: -7.14 vs OSSUY: 5.82

Embla Medical hf FCF Margin % Historical Data

The historical data trend for Embla Medical hf's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Embla Medical hf FCF Margin % Chart

Embla Medical hf Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

9.24

10.84

10.27

4.85

6.62

Embla Medical hf Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
FCF Margin %	Get a 7-Day Free Trial															-1.20	5.17	8.98	12.60	-3.73

Competitive Comparison of Embla Medical hf's FCF Margin %

For the Medical Devices subindustry, Embla Medical hf's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Embla Medical hf's FCF Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Embla Medical hf's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Embla Medical hf's FCF Margin % falls into.

Embla Medical hf FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Embla Medical hf's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	52.046	/	785.683
	=	6.62 %

Embla Medical hf's FCF Margin for the quarter that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	-7.446	/	199.852
	=	-3.73 %

Embla Medical hf FCF Margin % Related Terms

Thank you for viewing the detailed overview of Embla Medical hf's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Embla Medical hf (Embla Medical hf) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Embla Medical hf (OTCPK:OSSUY) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

OSSFF:USA OSSR:Denmark

Address

Grjothals 5, Reykjavik, ISL

Website

https://www.ossur.com

Ossur hf is engaged in the design, development, manufacture, and sale of prosthetics and bracing & support products. The company's products improve mobility through technologies in the field of braces, supports, prosthetic limbs, and compression therapy. Its segments are the Bracing & Supports and Prosthetics segment. The bracing & support products are used to support joints and other body parts for therapeutic and preventative purposes. The Prosthetics segment includes artificial limbs and related products for individuals born without limbs. Its geographical segments are the Americas; Europe, the Middle East & Africa (EMEA); and the Americas & Asia-Pacific (APAC), of which the Americas generate nearly half of the company's revenue.